Literature DB >> 25155931

Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype.

Maja Matic1, Sinno H P Simons, Richard A van Lingen, Joost van Rosmalen, Laure Elens, Saskia N de Wildt, Dick Tibboel, Ron H N van Schaik.   

Abstract

AIM: Determine whether SNPs of OPRM1 118A>G (asn(40)asp), COMT 472G>A (val(158)met) and ARRB2 8622C>T are associated with morphine rescue in newborns on mechanical ventilation. MATERIALS &
METHODS: This is a pharmacogenetic analysis of a randomized controlled trial in (pre)term newborns (n = 64) at a level III Neonatal Intensive Care Unit (NICU) who received placebo infusion and for whom need and dose for rescue morphine was documented.
RESULTS: For OPRM1 and COMT separately, the expected risk for rescue morphine or morphine dose was not significantly increased. However, the combined OPRM1/COMT 'high-risk' genotype lead to a significant association with the need for rescue (OR: 5.12; 95% CI: 1.12-23.3; p = 0.035). No association was found between OPRM1/COMT 'high-risk' genotype and total morphine dose administered.
CONCLUSION: Combined OPRM1 118A>G and COMT 472G>A genotype might serve as a predictor for the need of rescue morphine in premature and term newborns on mechanical ventilation.

Entities:  

Keywords:  COMT; OPRM1; morphine; newborns; pain; pediatric; pharmacogenetics; ventilation

Mesh:

Substances:

Year:  2014        PMID: 25155931     DOI: 10.2217/pgs.14.100

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  8 in total

Review 1.  The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review.

Authors:  Nadir Yalçin; Robert B Flint; Ron H N van Schaik; Sinno H P Simons; Karel Allegaert
Journal:  Pharmgenomics Pers Med       Date:  2022-06-30

Review 2.  Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.

Authors:  Anne Smits; John N van den Anker; Karel Allegaert
Journal:  J Pharm Pharmacol       Date:  2016-06-30       Impact factor: 3.765

Review 3.  Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.

Authors:  Joshua C Euteneuer; Suyog Kamatkar; Tsuyoshi Fukuda; Alexander A Vinks; Henry T Akinbi
Journal:  J Clin Pharmacol       Date:  2018-09-11       Impact factor: 3.126

Review 4.  Personalized pediatric anesthesia and pain management: problem-based review.

Authors:  Senthil Packiasabapathy; Valluvan Rangasamy; Nicole Horn; Michele Hendrickson; Janelle Renschler; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2020-01       Impact factor: 2.533

Review 5.  Neonatal pain management: still in search for the Holy Grail.

Authors:  Karel Allegaert; John N van den Anker
Journal:  Int J Clin Pharmacol Ther       Date:  2016-07       Impact factor: 1.366

6.  Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.

Authors:  Elizabeth M J Lee; Karen Xu; Emma Mosbrook; Amanda Links; Jessica Guzman; David R Adams; Elise Flynn; Elise Valkanas; Camillo Toro; Cynthia J Tifft; Cornelius F Boerkoel; William A Gahl; Murat Sincan
Journal:  Genet Med       Date:  2016-06-02       Impact factor: 8.822

7.  Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18 months.

Authors:  Cecil M Y Chau; Colin J D Ross; Vann Chau; Anne R Synnes; Steven P Miller; Bruce Carleton; Ruth E Grunau
Journal:  EBioMedicine       Date:  2019-01-30       Impact factor: 8.143

8.  Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.

Authors:  Ersilia Lucenteforte; Alfredo Vannacci; Giada Crescioli; Niccolò Lombardi; Laura Vagnoli; Laura Giunti; Valentina Cetica; Maria Luisa Coniglio; Alessandra Pugi; Roberto Bonaiuti; Maurizio Aricò; Sabrina Giglio; Andrea Messeri; Roberto Barale; Lisa Giovannelli; Alessandro Mugelli; Valentina Maggini
Journal:  BMC Cancer       Date:  2019-01-31       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.